A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)

A Double-Blind, Multicenter, Randomized, Titrated-Dose, Placebo-Controlled, Study of MK0364 (4 mg to 8 mg) in Chronic Cigarette Smokers as an Aid for Smoking Cessation

The purpose of this study is to evaluate the safety and tolerability of an investigational drug that may help individuals to stop smoking.

Inclusion Criteria:

• Smoking greater than/equal to 10 cigarettes/day for at least 1 year
• Laboratory tests that meet the criteria of the study
• In overall good health as determined by the investigator

Exclusion Criteria:

• Psychiatric diagnoses
• Certain cancers
• Patients who use nicotine replacement therapy
• Patients on a diet regimen